Perovskite Solar (Oxford PV / First Solar proxy)

Thesis

Perovskite solar technology hit its commercialization inflection in 2024-2026. Oxford PV shipped the world's first commercial perovskite-silicon tandem modules in September 2024, then licensed patents to First Solar (NASDAQ: FSLR) in February 2026 and Trinasolar (exclusive China license). Hanwha Qcells achieved 28.6% tandem cell efficiency using mass-production processes, with commercial production planned for 2026. First Solar is the best public proxy for perovskite exposure. As the largest U.S. Solar manufacturer with the Oxford PV license, it will likely be the first Western company to mass-produce perovskite-silicon tandems. The efficiency gain from tandems (28-30%+ vs 22-24% for pure silicon) represents a step-function improvement that could reshape the solar industry's cost curve. Caelux offers a potentially faster route to market with its 'Active Glass' product that converts existing silicon panels to tandem performance without new factories needed. This is a private company but worth monitoring for a future investment route. Risks center on perovskite durability (degradation over 25+ year module lifetimes remains unproven at scale), Chinese manufacturing dominance in solar, and the fact that First Solar is already a large-cap with the perovskite thesis partially priced in.

Catalysts

• +Oxford PV licensing to First Solar and Trinasolar validates commercial viability
• +Hanwha Qcells 28.6% efficiency using mass-production processes, commercial production 2026
• +Caelux 'Active Glass' offering retrofit tandem performance without new factories

Risks

• -Perovskite durability over 25+ year module lifetimes unproven at scale
• -Chinese manufacturing dominance could commoditize tandem technology quickly
• -First Solar already large-cap with perovskite thesis partially priced in

Common questions